MedTrace Logo

Patient-centred Smartphone AI for Protecting Vision in Macular Disease

NCT05433766 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-03-10

No results posted yet for this study

Summary

Macular disease is the leading cause of blindness in the UK and age-related macular degeneration must undergo monitoring to determine if an injection into the eye is required that month \[required in 50% of visits\] - these patients are the 'frequent fliers' within ophthalmology units, visiting specialist hospital clinics on a monthly or bi-monthly basis. This project aims to create a home-monitoring algorithm that could in the future, enable the movement of 'monitoring' of chronic eye disease into the patients' homes: remotely identifying who does need an in-person appointment, and who can safely stay away from hospital.

Conditions

  • Age-Related Macular Degeneration

Sponsors & Collaborators

  • INNOVATEUK

    collaborator UNKNOWN

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • The Macular Society

    collaborator UNKNOWN

  • OKKO Health

    lead INDUSTRY

Principal Investigators

  • Alexander Foss, D.M · Nottingham University Hospitals NHS Trust

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-08
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433766 on ClinicalTrials.gov